# Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients

> **NCT06703372** · NA · COMPLETED · sponsor: **Hams Hamed Abdelrahman** · enrollment: 60 (actual)

## Conditions studied

- Xerostomia
- Diabetes Mellitus

## Interventions

- **OTHER:** Diode Laser 980 nm, 0.2W
- **OTHER:** Placebo Diode laser

## Key facts

- **NCT ID:** NCT06703372
- **Lead sponsor:** Hams Hamed Abdelrahman
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-20
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06703372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06703372, "Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06703372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*